Epigenomics AG

ECX
Real-time TRADEGATE AG - 07/23 11:36:08 am
1.795EUR
-0.84%
Prev.1.7150
Open1.7100
High1.7900
Low1.7100
Volume2 000
Financials
Sales 2019 4,94 M
EBIT 2019 -12,2 M
Net income 2019 -11,4 M
Finance 2019 3,57 M
Yield 2019 -
P/E ratio 2019 -4,65x
P/E ratio 2020 -10,3x
EV / Sales2019 11,8x
EV / Sales2020 6,16x
Capitalization 61,8 M
Company
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The...
Sector :
Bio Diagnostics & Testing
Calendar :
2019-08-07 Earnings Release
Trading Rating :
Investor Rating :
Latest news
05:05aEPIGENOMICS AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
07/15EPIGENOMICS AG : Chinese Patent Reexamination Department partially invalidates Epigenomics' patent claims for Septin9
EQ
07/11EPIGENOMICS : Receives MedTech Outlook's 2019 Top 10 In-Vitro Diagnostics Award
EQ
07/11Epigenomics AG Receives MedTech Outlook's 2019 Top 10 In-Vitro Diagnostics Award
GL
06/19EPIGENOMICS AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
06/17EPIGENOMICS AG : New Clinical Data Support the Utility of Epi proColon(R) Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome
EQ
06/17New Clinical Data Support the Utility of Epi proColonŽ Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome
GL
06/04EPIGENOMICS : to Participate in Raymond James Life Sciences and MedTech Conference in June
EQ